US · Healthcare

CNS Pharmaceuticals Inc (CNSP)

Biotechnology

CNS Pharmaceuticals Inc (CNSP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CNSP

P/E ratio

18.00

CNS Pharmaceuticals Inc (CNSP) — FAQ

What is CNSP's P/E ratio?

The price-to-earnings (P/E) ratio for CNS Pharmaceuticals Inc (CNSP) is 18.00 (data as of 2026-03-24).

Does CNS Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for CNS Pharmaceuticals Inc (CNSP). Check the MyAverix Finance app for the latest dividend data.

What sector is CNS Pharmaceuticals Inc in?

CNS Pharmaceuticals Inc (CNSP) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CNSP listed on?

CNSP is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)